Data Security and Protection Toolkit (DSPT) 2018/19
Please remember that your Data Security and Protection Toolkit for 2018/19 needs to be published by 31 March 2019. Currently, 59 of our member practices have registered on the new Toolkit, 49 of which have also completed their organisational profile.
The DSPT Start and Administrator Guides (attached below) provide an overview of the registration process; completing your organisational profile and Assertions through to publication of your Assessment.
Registration is at: https://www.dsptoolkit.nhs.uk/Account/Register - your email address and a valid organisation code is required.
Annual completion of the Toolkit demonstrates to the Information Commissioner’s Office that your Practice complies with its legal obligations. The CQC will also be able to view whether a submission has been made. With effect from 1 February 2015, the ICO has had the power to enforce an audit of GP surgeries under section 41A of the Data Protection Act (DPA). Please also check that your Data Protection Registration has not expired.
The CCG's IG Team will run regular uptake reports until the end of March 2019, any individual reminders required will be sent via the CCG's Primary Care Team.
Data Security and Protection Toolkit Start guide (all users)
Data Security and Protection Toolkit Administrator guide
Please contact the CCG’s IG team if you have any questions: CAPCCG.Infogov@nhs.net or 01223 7254451
NEW - Winter communications toolkit
The latest winter communications toolkit is now available on the Health Professionals website HERE. This toolkit provides a 'one-stop-shop' for resources to help GP practices raise awareness within their practice and local community. It includes posters and leaflets, articles/copy for websites and newsletters, suggested social media activity and images and infographics around the following:
Self care – treating winter illnesses at home
Being prepared - stocking up your medicine cabinet/repeat prescriptions
NHS services - guide to local NHS services
The toolkit will be updated on a regular basis to ensure the most up-to-date resources are available at all times. It also provides links to other resources and promotional for national campaigns such as ‘Help us Help You’ from NHS England and ‘Self Care Week’ from the Self Care Forum.
If you would like any further information or guidance on how to use any of these resources within your practice please contact the CCG communications team at email@example.com.
Stepping into my Shoes initiative
The Cambridge and Peterborough STP Leadership and OD Network has a priority to embed a system approach to talent management to maximise and retain talent within the system.
Integrated Care Systems require local health and care partners to work together in new and different ways, Stepping Into My Shoes is an initiative which supports local leaders to work together, learn and share knowledge from across the system with their teams and services to create public services that are more integrated based on the needs of the local population.
Stepping into my Shoes is a simple concept of matching learners and sharers together with the intention of a mutual learning opportunity. For further information please see the attached:
- Stepping into my Shoes Flyer
- Stepping into my Shoes Q&A
- Stepping into my Shoes Processes and Understanding
Please see below the latest developments from the world of healthcare Research and Innovation:
Eastern region announces world first for Rebo the NHS Research Robot!NHS research could not happen without patients and the public participating but raising awareness of opportunities to get involved can be a challenge. Therefore, to help spread the word the National Institute for Health Research (NIHR) in the Eastern region is launching the world's first video game to tell the story of how scientists have found treatments for health conditions like diabetes through research.
Non-urgent attendances to emergency departments are more common among younger adults-Adults aged 16 to 44 years are more likely to attend emergency departments for non-urgent presentations than older adults. They were more than three times more likely to present for non-urgent reasons than those over 65 years. Non-urgent attendances are also more common during out-of-hours periods, especially at night.
Do image-based warning labels reduce selection of sugary drinks by parents for their children? The use of warning labels on sugar sweetened beverages (SSBs) is considered by UK and US governments as a possible intervention to help tackle excess sugar consumption. Evidence for the impact of warning labels comes from their use on tobacco products, which suggests that both text- and image-based warnings can affect a range of effectiveness outcomes, including cessation-related behaviors.
The R&D team are located on the 4th floor of Lockton House. If you want to get in touch about our weekly research updates, please contact Sarah Hider (firstname.lastname@example.org).
You can also now follow the R&D team on Twitter: https://twitter.com/CPPrimaryCareR1
Vision for prevention document
The Department of Health and Social Care has launched a vision document for prevention, as part of the NHS Long Term Plan. The document talks about prevention being better than cure - read it here.
Marmot Review update
An update on the Marmot Review report into health inequalities, particularly for the most vulnerable people in society, has been published. The report, commissioned by NHS England, covering key facts, stats, and interventions can be read here.
East of England Ambulance Service (EEAST)
Dorothy Hosein named as interim CEO for Ambulance Service
The East of England Ambulance Service NHS Trust (EEAST) confirmed its new leader on November 01. They will be in post until a substantive CEO can be appointed. Read more here
Cambridgeshire and Peterborough NHS Foundation Trust (CPFT)
Help patients take part in local dementia research
In order to test and develop effective new treatments for dementia through three major studies, CPFT research teams urgently need referrals for suitable patients, family, friends and neighbours who could benefit from taking part in dementia research and would like to try new medications or therapeutic approaches. If you are caring for, or know anyone who might be eligible to participate, please get in touch directly with the study leads below. They will be happy to talk with potential participants and explain the studies in more detail, or answer any questions you might have about the research.
Patients and carers working with the Windsor Research Unit have shared very positive feedback on their experiences of research, which can be an enjoyable and rewarding experience to enhance care.
SYMBAD: Study of Mirtazapine for Agitation in Dementia
Agitation in dementia can cause significant problems and reduced quality of life for patients, families and carers. Medicines are available to help manage agitation, but it is not clear which treatments work best. This study is designed to evaluate the use of Mirtazapine versus placebo in treating agitation in people with dementia,and a research nurse will be regularly visiting the patient and carer to carry out assessments and safety checks. Anyone with a diagnosis of Alzheimer’s disease and regular or intermittent agitation can be referred to take part, and they need acarer or study partner available to support assessments and supervise medication. Please contact the study lead: Julie Philps on 01223 219527Julie.Philps@cpft.nhs.uk
BI425809 study for Alzheimer’s Disease patients and carers
This clinical research study is looking at a potential new treatment for mild to moderate Alzheimer’s Disease. The study team are currently seeking patients and their carers, who may wish to take part. You can refer anyone diagnosed with mild to moderate Alzheimer’s Disease who is able to provide written consent and answer questions about memory, thinking and reasoning, aged 55 years or over with a partner who can join every visit. Please contact the study team: Edward Stanton on 01223 219526 Edward.Stanton@cpft.nhs.uk or Naomi Thomas on 01223 219528 Naomi.Thomas@cpft.nhs.uk.
MISSION AD: Investigating treatment for early Alzheimer’s Disease
CPFT has joined a global study to investigate a drug to treat the early stages of Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI) due to AD. The Mission AD clinical research programme is evaluating the efficacy and safety of elenbecestat (E2609), an investigational drug which can reduce build-up of beta amyloid plaque and nerve cell damage, to see if it can help people with Alzheimer’s Disease in the future. The study runs over 24 months and needs participants aged 50-85 years, with a diagnosis of mild cognitive impairment or early Alzheimer’s Disease. They must be able to provide written consent and have a reliable informant or study partner to support them. Please contact the study lead: Marina Pankratova on 01223 219705 Marina.Pankratova@nhs.net.
Eastern Academic Health Science Network
Community Conversations about Medicines Initiative (CCMI)
Could you please help raise awareness of this initiative by sharing the attached flyer with your patient groups.
National Institute for Health and Care Excellence (NICE)
NICE Public Involvement Update Newsletter - November 2018
Please find attached the November 2018 Public Involvement Newsletter from NICE. Includes information about current NICE consultations and recently published guidance.
Red Whale & Macmillan Webinar
Primary Care Guide to Haematological Malignancies Webinar
Senior Clinical Lecturer & Consultant Haematologist at the University of Sheffield and Bloodwise Consultant, Dr Andrew Chantry, be joining Dr David Plume (GPwSI and Red Whale GP Update Cancer Course Director) for our next webinar in collaboration with Macmillan Cancer Support to discuss the big three haematological malignancies - Leukaemia, Myeloma and Lymphoma.
Cambridge City Council
Domestic Abuse Conference
Please see attached flyer for more information.
The inclusion of external courses and events within GP News does not imply endorsement by NHS Cambridgeshire and Peterborough CCG or any association with their operators.
| Disclaimer: Whilst every effort has been made to check external links are from a reliable source please be mindful when requested to input personal information into third party links. |